AI
Sunday, August 05, 2018 11:24:20 AM
Are you still long and strong with Inmed? Just as much confidence?
Yes I am. However, the timeline slipped when they delayed clinical trials into next year LOL. Still patient, but I don't expect much price movement until 2019. Hopefully, I'll be proven wrong.
They still have a world class management team, excellent technology in their bio-informatics and biosynthesis systems, and a strong drug pipeline. They'll do very well in the long run. It's a good time to load up for the long haul.
Les
